About Us
Mammoth Biosciences is harnessing the diversity of nature to power the next generation of CRISPR products. Through its discovery of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. With a distinguished team including co-founder and CRISPR-Cas genome editing co-inventor Jennifer Doudna, Mammoth is addressing challenges across healthcare, agriculture, environmental monitoring, biodefense, and more.
Leadership
Our leadership team is comprised of cutting edge scientific research and business achievement.
Scientific Advisory Board
-
Jennifer Doudna, Ph. D.
Chair of Scientific Advisory Board
UC Berkeley
-
Charles Chiu, M.D. Ph. D.
Diagnostics
UCSF
-
Matthew Binnicker, Ph.D.
Diagnostics
Mayo Clinic
-
Leslie S. Kean, M.D., Ph.D.
Therapeutics
Boston Children’s Hospital
-
Aravind Asokan, Ph.D.
Therapeutics
Duke University
-
Crystal Mackall, M.D.
Therapeutics
Stanford University
Contact Us

Mammoth Biosciences, Inc.
1000 Marina Blvd. Suite 600
Brisbane CA 94005